Mortality profile of myeloid and lymphoid leukemias in Brazil: 2000 to 2018 / Perfil de mortalidade por leucemias mieloide e linfoide no Brasil: 2000 a 2018

• Autor(a) principal: Cardoso, Mônica Christine Alves Cabral
• Data de Publicação: 2022
• Outros Autores: do Amaral, Regiane Cristina, da Silva, Shirlei Octacílio
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Veras
• Texto Completo: https://ojs.brazilianjournals.com.br/ojs/index.php/BRJD/article/view/45812
• topic: leukemia; lymphoid; myeloid; mortality.

Introduction: Leukemias, despite their declining mortality over the years, continue to be a major public health problem in Brazil. Objective: to analyze trends in mortality from myeloid leukemia (LM) and lymphoid leukemia (LL) in Brazil from 2000 to 2018, correlating with health services and municipal human development index (MHDI). Methods: Data were collected from DATASUS databases for the year 2000 to 2018, regarding mortality rate, number of specialized hospitals, MDHI, primary care coverage and population by state. Correlation analyzes were performed between the studied variables and time series analysis to measure trends over the years (VPA – annual percentage change). Results: Approximately 50% of the Brazilian states showed a tendency to increase mortality from LL and LM. The North and Northeast regions have higher APC and lower MDHI. There is a statistically significant difference between MHDI and referral hospitals (p = 0.000; r = 0.64) and MHDI with primary care (p = 0.034; r = -0.41). For LL, mortality is higher in men (p < 0.001). There was a statistically significant correlation for LL mortality rate in women with primary care coverage (p=0.049; r=-0.38). Conclusions: Approximately 50% of Brazilian states showed increasing mortality. Mortality is higher in men with LL. Mortality of women with LL is lower where there are more primary and referral centers.